MediaTek is is expanding its IoT modems and chipsets to support the 5G RedCap ‘reduced capacity’ technology.
The M60 modem IP and the MediaTek T300 chipset series are built in TSMC’s 6nm technology to drive the transition to 5G Standalone (SA) networks. These aim to support applications that need longer lasting and efficient battery life such as wearables, light-weight AR devices, IoT modules, and devices built with edge AI in mind.
RedCap is designed to take advantage of the evolution of 5G networks to the Standalone (SA) network architecture and promises to deliver reliability for devices that have low bandwidth requirements without the cost and complexity of typical 5G solutions.
The T300 is the world’s first 6nm Radio Frequency System-On-Chip (RFSOC) single die for RedCap and uses a single-core Arm Cortex-A35 in a significantly more compact PCB area. This supports up to 227 Mbps downlink and 122 Mbps uplink data rates.
Both the T300 series and the M60 5G modem IP support the 3GPP R17 standard and combine MediaTek’s UltraSave 4.0 power efficiency design with coverage enhancements and low latency, reducing unnecessary paging receptions. The M60 offers up to a 70% reduction in power consumption compared to similar 5G eMBB solutions and up to 75% power savings compared to 4G LTE solutions.
- First RedCap device emulation boosts 5G IoT
- Wireless test platform supports 5G RedCap and cellular IoT
- First 5G RedCap test case validations
“Our RedCap solutions are a significant part of our mission to democratize 5G, providing our customers the ability to optimize components and deliver 5G-enabled devices from a range of applications and a range of price points,” said JC Hsu, Corporate Senior Vice President at MediaTek. “The migration to 5G RedCap will replace legacy 4G/LTE solutions, offering significantly better power efficiency and more reliable user experiences compared to leading edge 5G eMMB modem solutions and legacy 4G LTE Cat 4 and Cat 6 devices.”
The MediaTek T300 series chipsets will sample in the first half of 2024, with commercial samples in the second half of 2024.